Venture Pharmaceuticals Corporation Stamford, CT - 06902

Venture Pharmaceuticals Corporation is categorized under Wholesale Pharmaceutical Products in Stamford, CT and active since 2010.

Venture Pharmaceuticals Corporation was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Ely Ceja at the company’s single location by writing to 20 Signal Road, Stamford, Connecticut CT 06902 or by phoning (203) 252-2595. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Venture Pharmaceuticals Corporation
Contact Person: Ely Ceja
Address: 20 Signal Road, Stamford, Connecticut 06902
Phone Number: (203) 252-2595
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Venture Pharmaceuticals Corporation was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Ely Ceja for inquiries that concern Venture Pharmaceuticals Corporation by calling the company number (203) 252-2595, as your correspondence is most welcome. Additionally, the physical location of the single location of Venture Pharmaceuticals Corporation can be found at the coordinates 41.027823,-73.551119 as well as the street address 20 Signal Road in Stamford, Connecticut 06902.

For its online presence, you may visit Venture Pharmaceuticals Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.